BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16702763)

  • 1. Effect of heptanol on noradrenaline-induced contractions in rat vas deferens.
    Palani D; Manchanda R
    J Smooth Muscle Res; 2006 Feb; 42(1):49-61. PubMed ID: 16702763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of heptanol and carbenoxolone on noradrenaline induced contractions in guinea pig vas deferens.
    Palani D; Ghildyal P; Manchanda R
    Auton Neurosci; 2007 Dec; 137(1-2):56-62. PubMed ID: 17716954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heptanol on neurogenic contractions of vas deferens: A comparative study of stimulation frequency in guinea pig and rat.
    Palani D; Manchanda R
    J Physiol Sci; 2006 Feb; 56(1):21-8. PubMed ID: 16779910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of some organic calcium antagonists and other procedures affecting Ca2+ Translocation on KCl-induced contractions in the rat vas deferens.
    Hay DW; Wadsworth RM
    Br J Pharmacol; 1982 May; 76(1):103-13. PubMed ID: 7082900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different actions in the rat prostatic and epididymal vas deferens of cyclopiazonic acid or ryanodine on noradrenaline-induced contractions.
    Amobi NI; Smith IC
    Gen Pharmacol; 1999 Feb; 32(2):271-8. PubMed ID: 10188631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium antagonists on the response to noradrenaline in the whole and bisected rat vas deferens.
    Boselli C; Bianchi L; Barbieri A; Grana E
    J Auton Pharmacol; 1998 Oct; 18(5):297-306. PubMed ID: 9831230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-mediated inhibition of noradrenaline-induced contraction and Ca2+ influx in guinea-pig vas deferens.
    Kato K; Furuya K; Tsutsui I; Ozaki T; Yamagishi S
    Exp Physiol; 2000 Jul; 85(4):387-98. PubMed ID: 10918078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ryanodine and nifedipine on contractions induced by norepinephrine, acetylcholine, and potassium in the isolated vas deferens of the guinea pig.
    Tsunobuchi H; Gomi Y
    J Pharmacobiodyn; 1990 Sep; 13(9):574-80. PubMed ID: 2084228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of T-type and L-type Ca(2+)-antagonists against noradrenaline-induced contractions of human vas deferens.
    Amobi N; Guillebaud J; Smith CH
    BJU Int; 2010 Aug; 106(4):578-85. PubMed ID: 20002677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium-entry modulators on the biphasic neurogenic contractions in the circular muscle of guinea pig vas deferens.
    Suzuki N; Gomi Y
    Jpn J Pharmacol; 1989 Jan; 49(1):59-65. PubMed ID: 2470942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BaCl2- and 4-aminopyridine-evoked phasic contractions in the rat vas deferens.
    Huang Y
    Br J Pharmacol; 1995 Jul; 115(5):845-51. PubMed ID: 8548186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
    Bültmann R; Kurz AK; Starke K
    Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contractile effects of 5-hydroxytryptamine on the rat isolated vas deferens.
    Hay DW; Wadsworth RM
    Br J Pharmacol; 1982 Dec; 77(4):605-13. PubMed ID: 7150868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nifedipine and ryanodine on adrenergic neurogenic contractions of rat vas deferens: evidence for a pulse-to-pulse change in Ca2+ sources.
    Bültmann R; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Apr; 108(4):1062-70. PubMed ID: 8485618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of ryanodine and calcium channel blockers to characterize intra- and extracellular calcium pools mobilized by noradrenaline in the rat vas deferens.
    Vesperinas G; Feddersen M; Lewin J; Huidobro-Toro JP
    Eur J Pharmacol; 1989 Jun; 165(2-3):309-13. PubMed ID: 2776834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ryanodine- and cyclopiazonic acid-sensitive components in human vas deferens contractions to noradrenaline.
    Amobi NI; Smith IC
    J Auton Pharmacol; 1998 Jun; 18(3):167-76. PubMed ID: 9754637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage and time dependency of calcium mediated phasic and tonic responses in rat vas deferens smooth muscle--the effect of some calcium agonist and antagonist agents.
    Langton PD; Huddart H
    Gen Pharmacol; 1988; 19(6):775-87. PubMed ID: 2465934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.